Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 4301-4350 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05971251
Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
PHASE1Active, not recruiting
24 participants
Started: Dec 18, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06301217
Are Axioscapular Muscles Activity and Cervical Curvature Associated With Disability in Neck Pain
N/AActive, not recruiting
60 participants
Started: Dec 17, 2023 · Completed: Mar 20, 2024
2 conditions1 sponsor1 location
NCT06223919
Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
PHASE3Active, not recruiting
8,686 participants
Started: Dec 16, 2023 · Completed: Dec 31, 2025
1 condition7 sponsors3 locations
NCT06217692
The Effect of Nutrition Education Hemodialysis Patients
NAActive, not recruiting
40 participants
Started: Dec 15, 2023 · Completed: Aug 2, 2024
1 condition1 sponsor1 location
NCT06043713
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
PHASE1Active, not recruiting
5 participants
Started: Dec 15, 2023 · Completed: Feb 9, 2026
1 condition2 sponsors1 location
NCT06172088
Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy
NAActive, not recruiting
54 participants
Started: Dec 15, 2023 · Completed: Sep 30, 2025
1 condition3 sponsors2 locations
NCT06823986
Extraction Space Consumption and Overjet Reduction After Maxillary Anterior Enmasse Retraction in Orthodontics
NAActive, not recruiting
20 participants
Started: Dec 15, 2023 · Completed: Apr 15, 2026
1 condition1 sponsor1 location
NCT06813469
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome
NAActive, not recruiting
15 participants
Started: Dec 15, 2023 · Completed: Mar 15, 2025
1 condition1 sponsor1 location
NCT06063213
Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation
N/AActive, not recruiting
40 participants
Started: Dec 15, 2023 · Completed: Oct 15, 2026
1 condition2 sponsors1 location
NCT07064499
CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes
N/AActive, not recruiting
440 participants
Started: Dec 15, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06435091
REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data
N/AActive, not recruiting
40 participants
Started: Dec 15, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05891431
Engagement and Acceptability of the Untire mHealth App
NAActive, not recruiting
34 participants
Started: Dec 15, 2023 · Completed: Oct 1, 2025
2 conditions2 sponsors2 locations
NCT06176976
Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study
NAActive, not recruiting
50 participants
Started: Dec 15, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06332872
Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand
PHASE4Active, not recruiting
117 participants
Started: Dec 15, 2023 · Completed: May 31, 2024
7 conditions1 sponsor1 location
NCT06029894
Improving Sleep and AD Biomarkers
NAActive, not recruiting
100 participants
Started: Dec 15, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors2 locations
NCT06176339
"Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"
PHASE2Active, not recruiting
70 participants
Started: Dec 15, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06084884
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
PHASE1/PHASE2Active, not recruiting
94 participants
Started: Dec 14, 2023 · Completed: Dec 13, 2027
1 condition1 sponsor20 locations
NCT06111235
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
PHASE3Active, not recruiting
367 participants
Started: Dec 14, 2023 · Completed: Jan 31, 2030
4 conditions1 sponsor95 locations
NCT06344637
Effects of Cervical Lidocaine Spray on Pain Relief During Manual Vacuum Aspiration
NAActive, not recruiting
216 participants
Started: Dec 14, 2023 · Completed: Jul 30, 2024
3 conditions1 sponsor1 location
NCT06137274
Pilot Trial of Adaptive Radiotherapy Boost for HNSCC
NAActive, not recruiting
25 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT06099730
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
NAActive, not recruiting
360 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor7 locations
NCT06135324
Impairments That Affect Correct Inhaler Use in COPD
N/AActive, not recruiting
500 participants
Started: Dec 14, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors9 locations
NCT06965075
The SCULPT-Job Cohort Study
NAActive, not recruiting
15 participants
Started: Dec 14, 2023 · Completed: Jun 30, 2025
8 conditions2 sponsors1 location
NCT05599490
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
NAActive, not recruiting
180 participants
Started: Dec 14, 2023 · Completed: Apr 1, 2026
1 condition3 sponsors2 locations
NCT05922904
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
PHASE2Active, not recruiting
25 participants
Started: Dec 14, 2023 · Completed: Oct 30, 2027
1 condition3 sponsors1 location
NCT05286827
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
PHASE2Active, not recruiting
20 participants
Started: Dec 14, 2023 · Completed: Dec 18, 2025
1 condition1 sponsor1 location
NCT06708208
Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :
N/AActive, not recruiting
107 participants
Started: Dec 14, 2023 · Completed: Dec 20, 2024
7 conditions1 sponsor1 location
NCT06082635
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
321 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT05554367
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
PHASE2Active, not recruiting
199 participants
Started: Dec 13, 2023 · Completed: Aug 26, 2026
5 conditions1 sponsor267 locations
NCT06304233
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
N/AActive, not recruiting
120 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2038
3 conditions2 sponsors2 locations
NCT06101342
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
PHASE2Active, not recruiting
181 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
1 condition4 sponsors9 locations
NCT06074497
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.
PHASE1Active, not recruiting
54 participants
Started: Dec 13, 2023 · Completed: May 30, 2026
1 condition1 sponsor3 locations
NCT06127030
Brief Behavioral Teacher Training for Behavioral Difficulties
NAActive, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05951959
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
PHASE2Active, not recruiting
108 participants
Started: Dec 13, 2023 · Completed: Jul 7, 2028
1 condition1 sponsor29 locations
NCT06830070
Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy
N/AActive, not recruiting
70 participants
Started: Dec 13, 2023 · Completed: May 31, 2025
3 conditions1 sponsor1 location
NCT06179446
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
PHASE1Active, not recruiting
157 participants
Started: Dec 13, 2023 · Completed: Sep 25, 2025
3 conditions1 sponsor4 locations
NCT06058793
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
PHASE3Active, not recruiting
138 participants
Started: Dec 13, 2023 · Completed: Oct 7, 2025
1 condition1 sponsor56 locations
NCT07049289
Telemonitoring in Arterial Hypertension
NAActive, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Sep 9, 2025
2 conditions1 sponsor1 location
NCT06170671
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
N/AActive, not recruiting
250 participants
Started: Dec 13, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor19 locations
NCT05174884
Casea S Contraceptive Implants (Casea S) Trial
PHASE1Active, not recruiting
20 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
PHASE3Active, not recruiting
904 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2029
1 condition1 sponsor149 locations
NCT05971160
Creating Access to Resources and Economic Support
NAActive, not recruiting
360 participants
Started: Dec 12, 2023 · Completed: Feb 19, 2026
1 condition2 sponsors1 location
NCT06185023
Effects of High-intensity Exercise Training on Physical Fitness, Cognition, Language in Post-stroke Aphasia
NAActive, not recruiting
12 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
4 conditions4 sponsors4 locations
NCT06160908
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)
NAActive, not recruiting
38 participants
Started: Dec 12, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05821231
Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
PHASE1Active, not recruiting
20 participants
Started: Dec 12, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors5 locations
NCT05991323
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
N/AActive, not recruiting
100 participants
Started: Dec 12, 2023 · Completed: Sep 22, 2026
1 condition2 sponsors49 locations
NCT06204809
Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
PHASE1Active, not recruiting
24 participants
Started: Dec 12, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor12 locations
NCT06200896
Early Feasibility Study: Assessment of Self-Forming Magnetic Anastomosis Device and Delivery System (SFM) in Obese Patients, When Used to Create a Duodenal-Ileal Anastomosis Post SG (SNAP-PS), or Used to Create a Jejuno-Jejunal (J-J) Anastomosis
NAActive, not recruiting
28 participants
Started: Dec 12, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06742372
Effects of Combined Exercise Training Modality
NAActive, not recruiting
24 participants
Started: Dec 12, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06276998
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis
PHASE3Active, not recruiting
430 participants
Started: Dec 12, 2023 · Completed: Nov 20, 2026
1 condition1 sponsor1 location